| Autor: |
Turnes, Juan, Rincón, Diego, Calleja, José L., Delgado, Manuel B., Rosales, José M., Andrade, Raúl J., Manzano, María L., Salmerón, Francisco J., López, María A., Calvo, Marta, Gómez, Judith, Molina, Esther, Frias, Yza Nubia, Gálvez-Fernández, Roque Miguel, Vallejo-Senra, Nicolau, París, Sara, Santos de Lamadrid, Regina, Olveira, Antonio |
| Zdroj: |
Gastroenterología y Hepatología (ScienceDirect); 20210101, Issue: Preprints |
| Abstrakt: |
The emergence of highly tolerable, effective, and shorter duration direct-acting antivirals (DAAs) regimens offers the opportunity to simplify hepatitis C virus management but medical costs are unknown. Thus, we aimed to determine the direct medical costs associated with a combo-simplified strategy (one-step diagnosis and low monitoring) to manage HCV infection within an 8-week glecaprevir/pibrentasvir (GLE/PIB) regimen in clinical practice in Spain. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
